<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Ramipril - Drug Monograph</title>
  <style>
    body {
      font-family: Arial, sans-serif;
      margin: 40px;
      background-color: #f9f9f9;
      color: #333;
    }
    h1, h2 {
      color: #005580;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin: 20px 0;
    }
    th, td {
      border: 1px solid #ccc;
      padding: 10px;
      text-align: left;
    }
    th {
      background-color: #e3f2fd;
    }
    ul {
      margin: 0;
      padding-left: 20px;
    }
    .logo {
      display: block;
      margin: 0 auto 30px auto;
      width: 160px;
    }
  </style>
</head>
<body>

  <!-- Clickable UMT Logo -->
  <a href="https://umt.edu.pk" target="_blank">
    <img src="https://umt.edu.pk/images/logo.png" alt="UMT Logo" class="logo">
  </a>

  <h1>Biopharmaceutics Assignment</h1>
  <h2>Submitted To:</h2>
  <p>Sir Maaz Munir</p>
  <h2>Submitted By:</h2>
  <p>Toqeer Ameer Hussain | F2021437082</p>

  <h2>Ramipril - Drug Monograph</h2>

  <h3>Introduction</h3>
  <p>Ramipril is an ACE inhibitor used for the treatment of hypertension and reduction of cardiovascular mortality following myocardial infarction in hemodynamically stable patients.</p>

  <h3>Chemical Formula</h3>
  <p><strong>C<sub>23</sub>H<sub>32</sub>N<sub>2</sub>O<sub>5</sub></strong></p>

  <h3>Therapeutic Category</h3>
  <ul>
    <li>ACE Inhibitor</li>
    <li>Antihypertensive Agent</li>
    <li>Acts on Renin-Angiotensin System</li>
  </ul>

  <h3>Dosage Forms</h3>
  <ul>
    <li>Oral tablets and capsules</li>
    <li>Strengths: 1.25mg, 2.5mg, 5mg, 10mg</li>
  </ul>

  <h3>Indications</h3>
  <ul>
    <li>Hypertension</li>
    <li>Cardiovascular risk reduction</li>
    <li>Post-myocardial infarction (MI)</li>
    <li>Congestive heart failure</li>
  </ul>

  <h3>Mechanism of Action</h3>
  <p>Ramipril is a prodrug converted to ramiprilat in the liver. It inhibits ACE, reducing Angiotensin II and increasing bradykinin levels, resulting in vasodilation and reduced aldosterone secretion.</p>

  <h3>Pharmacokinetics</h3>
  <ul>
    <li><strong>Absorption:</strong> 50â€“60%; food slows rate but not extent</li>
    <li><strong>Bioavailability:</strong> Ramipril 28%, Ramiprilat 44%</li>
    <li><strong>Volume of Distribution:</strong> ~0.9 L/kg (Ramipril), ~0.8 L/kg (Ramiprilat)</li>
    <li><strong>Protein Binding:</strong> Ramipril 73%, Ramiprilat 56%</li>
    <li><strong>Metabolism:</strong> Hepatic via esterase to ramiprilat</li>
    <li><strong>Excretion:</strong> 60% urine, 40% feces</li>
    <li><strong>Half-life:</strong> 13â€“36 hours depending on dose</li>
    <li><strong>Clearance:</strong> Ramipril 10.7 mL/min, Ramiprilat 126.8 mL/min</li>
  </ul>

  <h3>Adverse Effects</h3>
  <ul>
    <li>Dry cough, chest pain, dizziness, hyperkalemia</li>
    <li>Neutropenia, shakiness, impotence</li>
  </ul>

  <h3>Contraindications</h3>
  <ul>
    <li>Volume depletion</li>
    <li>Angioedema history</li>
    <li>Hypotension</li>
    <li>Hyperkalemia</li>
  </ul>

  <h3>Pregnancy</h3>
  <p><strong>Category D:</strong> Contraindicated during 2nd and 3rd trimesters due to fetal risk.</p>

  <h3>Drug Interactions</h3>
  <ul>
    <li><strong>Food:</strong> Avoid potassium products. Food doesn't affect absorption.</li>
    <li><strong>Drugs:</strong> Albuterol may reduce effect; NSAIDs may increase renal risk</li>
    <li><strong>Disease:</strong> Monitor in renal artery stenosis</li>
  </ul>

  <h3>Off-label Uses</h3>
  <ul>
    <li>Diabetic nephropathy</li>
    <li>Chronic kidney disease</li>
    <li>Prevention of migraines</li>
  </ul>

  <h3>Dosing Schedule</h3>
  <table>
    <tr>
      <th>Condition</th><th>Initial Dose</th><th>Maintenance Dose</th><th>Min Dose</th><th>Max Dose</th><th>Notes</th>
    </tr>
    <tr><td>Hypertension (Adults)</td><td>2.5 mg daily</td><td>2.5â€“20 mg/day</td><td>1.25 mg</td><td>20 mg</td><td>Monitor BP and renal function</td></tr>
    <tr><td>Heart Failure (Post-MI)</td><td>2.5 mg twice daily</td><td>Up to 5 mg BID</td><td>2.5 mg</td><td>10 mg</td><td>Start within days post-MI</td></tr>
    <tr><td>CV Risk Reduction</td><td>2.5 mg â†’ 5 mg</td><td>10 mg</td><td>2.5 mg</td><td>10 mg</td><td>Step-up dosing</td></tr>
    <tr><td>Renal Impairment (CrCl &lt; 40)</td><td>1.25 mg</td><td>Titrate carefully</td><td>1.25 mg</td><td>5 mg</td><td>Monitor creatinine</td></tr>
    <tr><td>Heart Failure + Renal</td><td>1.25 mg</td><td>1.25â€“2.5 mg BID</td><td>1.25 mg</td><td>5 mg</td><td>Split dose recommended</td></tr>
    <tr><td>Elderly (65+)</td><td>1.25â€“2.5 mg</td><td>Per response</td><td>1.25 mg</td><td>10â€“20 mg</td><td>Monitor closely</td></tr>
    <tr><td>Children</td><td>Not recommended</td><td>â€”</td><td>â€”</td><td>â€”</td><td>Only under specialist</td></tr>
    <tr><td>Patients on Diuretics</td><td>1.25 mg</td><td>Adjust by BP</td><td>1.25 mg</td><td>â€”</td><td>Withhold diuretic if possible</td></tr>
  </table>

  <h3>Common Brands in Pakistan</h3>
  <table>
    <tr><th>Brand</th><th>Form</th><th>Manufacturer</th></tr>
    <tr><td>Ramipace</td><td>Tablet</td><td>Pharm Evo (PVT) Ltd</td></tr>
    <tr><td>Ramy</td><td>Tablet</td><td>Getz Pharma</td></tr>
    <tr><td>Tritace</td><td>Tablet</td><td>Sanofi Aventis</td></tr>
    <tr><td>Lipra</td><td>Tablet</td><td>Pfizer Laboratories</td></tr>
  </table>

  <h3>References</h3>
  <ul>
    <li><a href="https://go.drugbank.com/drugs/DB00178" target="_blank">DrugBank â€“ Ramipril</a></li>
    <li><a href="https://en.wikipedia.org/wiki/Ramipril#Medical_uses" target="_blank">Wikipedia â€“ Ramipril</a></li>
    <li><a href="https://www.drugs.com/search.php?searchterm=BRANDS+OF+RAMIPRIL" target="_blank">Drugs.com â€“ Ramipril Brands</a></li>
    <li><a href="https://www.druginfosys.com/AvailableBrands.aspx?query=2.5%20mg&form=Tabs&drugCode=643&drugName=Ramipril&Ing==1" target="_blank">DrugInfoSys â€“ Ramipril</a></li>
    <li><a href="https://reference.medscape.com/drug/altace-ramipril-342331" target="_blank">Medscape â€“ Altace (Ramipril)</a></li>
  </ul>

</body>
</html>
<!-- Download PDF Button -->
<p style="text-align: center;">
  <a href="ramipril.pdf" download style="background-color: #0074b7; color: white; padding: 10px 20px; text-decoration: none; border-radius: 5px; font-weight: bold;">
    ðŸ“¥ Download PDF Version
  </a>
</p>
